Follow
Erik Roberson
Title
Cited by
Cited by
Year
Reducing endogenous tau ameliorates amyloid ß-induced deficits in an Alzheimer's disease mouse model
ED Roberson, K Scearce-Levie, JJ Palop, F Yan, IH Cheng, T Wu, ...
Science 316 (5825), 750-754, 2007
23072007
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
21312019
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
21262011
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
JJ Palop, J Chin, ED Roberson, J Wang, MT Thwin, N Bien-Ly, J Yoo, ...
Neuron 55 (5), 697-711, 2007
16782007
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
9792016
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
8882017
Amyloid-β/Fyn–induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease
ED Roberson, B Halabisky, JW Yoo, J Yao, J Chin, F Yan, T Wu, P Hamto, ...
Journal of Neuroscience 31 (2), 700-711, 2011
7422011
100 years and counting: prospects for defeating Alzheimer's disease
ED Roberson, L Mucke
science 314 (5800), 781-784, 2006
7382006
The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus
ED Roberson, JD English, JP Adams, JC Selcher, C Kondratick, ...
Journal of Neuroscience 19 (11), 4337-4348, 1999
6641999
Frontotemporal lobar degeneration: demographic characteristics of 353 patients
JK Johnson, J Diehl, MF Mendez, J Neuhaus, JS Shapira, M Forman, ...
Archives of neurology 62 (6), 925-930, 2005
5552005
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease
S Mueller-Steiner, Y Zhou, H Arai, ED Roberson, B Sun, J Chen, X Wang, ...
Neuron 51 (6), 703-714, 2006
5222006
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes
G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ...
Archives of neurology 67 (12), 1473-1484, 2010
4962010
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
4652016
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
KA Vossel, KG Ranasinghe, AJ Beagle, D Mizuiri, SM Honma, ...
Annals of neurology 80 (6), 858-870, 2016
4252016
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
DC Whitcomb, J LaRusch, AM Krasinskas, L Klei, JP Smith, RE Brand, ...
Nature genetics 44 (12), 1349-1354, 2012
3972012
Mouse models of Alzheimer's disease
AM Hall, ED Roberson
Brain research bulletin 88 (1), 3-12, 2012
3972012
Frontotemporal dementia progresses to death faster than Alzheimer disease
ED Roberson, JH Hesse, KD Rose, H Slama, JK Johnson, K Yaffe, ...
Neurology 65 (5), 719-725, 2005
3802005
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
2882014
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
H Qiu, S Lee, Y Shang, WY Wang, KF Au, S Kamiya, SJ Barmada, ...
The Journal of clinical investigation 124 (3), 981-999, 2014
2882014
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
2872015
The system can't perform the operation now. Try again later.
Articles 1–20